Prominent basement membrane surrounding and within tumor nodules reminiscent of skin adnexal and salivary gland neoplasms
Has been given several names
Cylindroma
Adenoid cystic carcinoma
Spiradenocylindroma
Lacks any myoepithelial layer
Rare as a dominant pattern
No clear clinical difference has been demonstrated for any of these types and patterns of differentiation or degrees of differentiation with modern therapy
Diagnosis should simply be Squamous Carcinoma
Descriptive features may be included in a comment
A few studies from the pre-modern therapy era suggested that the mucinous microcystic pattern and the small cell (anaplastic) carcinoma had a worse outcome
Old version of WHO classification is no longer followed:
Large cell keratinizing, large cell non-keratinizing and basaloid
The classification shows poor reproducibility and is not clinically relevant
Teri A Longacre MD
Robert V Rouse MD
Department of Pathology
Stanford University School of Medicine
Stanford CA 94305-5342
Original posting/updates : 10/7/10, 11/13/11
Supplemental studies
Immunohistology
Usually positive:
p63
High molecular weight keratins (CK5/6, 34BE12)
AE1 (CK 10,14 15, 16, 19)
Variable reports for CK7
Usually negative markers
CAM5.2 (CK 8, 18) (one report)
CK20
Genetic analysis
High risk human papilloma virus (HPV) can be demonstrated in >90% of cases
Longacre TA, Kong CS, Welton ML. Diagnostic problems in anal pathology. Adv Anat Pathol. 2008 Sep;15(5):263-78.
Shepherd NA, Scholefield JH, Love SB, England J, Northover JM. Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. Histopathology. 1990 Jun;16(6):545-55.
Friberg B, Svensson C, Goldman S, Glimelius B. The Swedish National Care Programme for Anal Carcinoma--implementation and overall results. Acta Oncol. 1998;37(1):25-32.
Pang LS, Morson BC. Basaloid carcinoma of the anal canal. J Clin Pathol. 1967 Mar;20(2):128-35.
Nahas CS, Shia J, Joseph R, Schrag D, Minsky BD, Weiser MR, Guillem JG, Paty PB, Klimstra DS, Tang LH, Wong WD, Temple LK. Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum. 2007 Sep;50(9):1393-400.
Roohipour R, Patil S, Goodman KA, Minsky BD, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LK. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum. 2008 Feb;51(2):147-53. Erratum in: Dis Colon Rectum. 2008 May;51(5):620.
Khanfir K, Ozsahin M, Bieri S, Cavuto C, Mirimanoff RO, Zouhair A. Patterns of failure and outcome in patients with carcinoma of the anal margin. Ann Surg Oncol. 2008 Apr;15(4):1092-8.
Owens SR, Greenson JK. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas. Am J Surg Pathol. 2007 Feb;31(2):285-90.
Balachandra B, Marcus V, Jass JR. Poorly differentiated tumours of the anal canal: a diagnostic strategy for the surgical pathologist. Histopathology. 2007 Jan;50(1):163-74.
Behrendt GC, Hansmann ML. Carcinomas of the anal canal and anal margin differ in their expression of cadherin, cytokeratins and p53. Virchows Arch. 2001 Dec;439(6):782-6.
Kacerovska D, Szepe P, Vanecek T, Nemcova J, Michal M, Mukensnabl P, Kazakov DV. Spiradenocylindroma-like basaloid carcinoma of the anus and rectum: case report, including HPV studies and analysis of the CYLD gene mutations. Am J Dermatopathol. 2008 Oct;30(5):472-6.
Chetty R, Serra S, Hsieh E. Basaloid squamous carcinoma of the anal canal with an adenoid cystic pattern: histologic and immunohistochemical reappraisal of an unusual variant. Am J Surg Pathol. 2005 Dec;29(12):1668-72.
Fenger C, Frisch M, Jass JJ, Williams GT, Hilden J. Anal cancer subtype reproducibility study. Virchows Arch. 2000 Mar;436(3):229-33.
Alvarez-Cañas MC, Fernández FA, Rodilla IG, Val-Bernal JF. Perianal basal cell carcinoma: a comparative histologic, immunohistochemical, and flow cytometric study with basaloid carcinoma of the anus. Am J Dermatopathol. 1996 Aug;18(4):371-9.